ConductScience.org, home

Comparison · NCT01002742-2e7222fd

Mycophenolate Mofetil vs Placebo: Incidence of Systemic Infections

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Mycophenolate Mofetil vs Placebo: Incidence of Systemic Infections. Trial comparisons, record NCT01002742-2e7222fd. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01002742-2e7222fd

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.6980.6090.774wilson
Risk in group 20.6470.5580.727wilson
Risk difference, group 1 minus group 20.0512-0.06830.168newcombe hybrid score
Risk ratio, group 1 over group 21.080.9031.29log
Odds ratio, group 1 over group 21.260.7312.18log
Number needed to treat, for one more participant with the outcome on Mycophenolate Mofetil than on Placebo19.5from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Mycophenolate MofetilCorticosteroids with Mycophenolate Mofetil81116OG001
Group 2PlaceboCorticosteroids with placebo77119OG000

Outcome

Type
SECONDARY
Title
Incidence of Systemic Infections
Description
Number of participants that experienced at least one infection.
Time frame
6 Months
Population

Source ClinicalTrials.gov

Trial

Title
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
NCT number
NCT01002742
Phases
PHASE3
Conditions
Graft-versus-Host Disease, Immune System Disorders
Interventions
Mycophenolate Mofetil, Placebo
Lead sponsor
Medical College of Wisconsin
Results first posted
2016-05-27

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01002742-2e7222fd